Delivery Order SPE2DB22D2206-SPE2DB24FEJ78

Award Date 11/29/23
Potential Completion Date 11/30/23
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 30, 2023. The $1,530.38 firm fixed-price delivery order is for the supply of 4561390219 NOREPINEPHRINE 4 MG/250 ML-D5W 250ML, a critical medication used in healthcare settings. The contract has a completion date of July 3, 2023 and is not designated as a set-aside requirement. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,016.76, is for the delivery of a medical product, specifically 4563886967 ! NOREPINEPHRINE 8 MG/250 ML-D5W 250ML. The contract has a firm fixed price and an ultimate completion date of March 8, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,611.04, is for the delivery of 4567644030 - NOREPINEPHRINE 8 MG/250 ML-D5W 250ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 21, 2025. The contract is not designated as a set-aside award. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,128.28 firm-fixed-price contract is for the supply of 4566915797 NOREPINEPHRINE 8 MG/250 ML-D5W 250ML medical supplies. The contract has an ultimate completion date of January 14, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of norepinephrine 8 mg/250 ml-D5W 250ml. The contract, valued at $2,796.06, is a firm fixed-price delivery order with a completion date of July 15, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,759.11, is for the delivery of a 250 mL bag of norepinephrine 8 mg/250 mL in D5W. This is a firm fixed-price delivery order contract with a completion date of January 23, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award, with the ID SPE2DB22D3501|SPE2DB24FWV06, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4565644183 - Norepinephrine 8 mg/250 ml-D5W 250ml. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $4,927.88 and an ultimate completion date of September 3, 2024. This award is not associated with any set-aside designation. AmerisourceBergen, through its Corporate...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,081.44 firm fixed price contract is for the delivery of 4,565,599,173 milligrams of norepinephrine 8 milligram/250 milliliter 0.9% sodium chloride solution. The contract has an ultimate completion date of August 28, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts...
This federal contract award is for the delivery of 4 mg/4 ml vials of the pharmaceutical drug norepinephrine, with a ceiling value of $2,008.70. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,532.55, is for the delivery of 4 mg/4 ml vials of norepinephrine, a critical medication used in various medical treatments. The contract is a Firm Fixed Price Delivery Order that runs through February 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FEJ78
    Delivery Order

This federal contract award, valued at $10,474.54, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is a Delivery Order for the procurement of 4562939606 - NOREPINEPHRINE 4 MG/4 ML VIAL 4ML, with an ultimate completion date of November 30, 2023.

AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company maintains a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is part of that broader IDC. The contract does not have a set-aside designation, indicating open competition.

Generated 5/12/25, 10:39 AM